EDAP TMS S.A. (EDAP)

[jupp]

EDAP TMS today announced the first successful treatments performed at Germany's Mannheim University Hospital ("UMM"), using the Company's Focal One® HIFU device.

Marc Oczachowski, EDAP's Chief Executive Officer, added, "We are very pleased to add one of the largest German Prostate Cancer Centers, Mannheim University Hospital, to our growing number of Focal One adopters. This trend confirms the positioning of our Focal One HIFU system as a viable complement to current prostate cancer treatments at leading Institutions."

EDAP TMS recently presented its innovative technologies at the 66th Congress of the German Society of Urology held October 1 – 4, 2014, in Dusseldorf, Germany. The Company's presentation included live Focal One demonstrations, which were well-attended by urologists. Feedback from the demonstrations confirmed significant physician interest in adopting this HIFU tool to address the needs of prostate cancer patients.

www.marketwatch.com/story/edap-announces-sale-of-focal-oner-hifu-device-to-mannheim-university-hospital-germany-2014-10-07?siteid=nbsh